Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Enterococcus peptidoglycan remodeling promotes checkpoint inhibitor cancer immunotherapy
Matthew E. Griffin, Juliel Espinosa, Jessica L. Becker, et al.
Science (2021) Vol. 373, Iss. 6558, pp. 1040-1046
Open Access | Times Cited: 252

Showing 1-25 of 252 citing articles:

Hallmarks of Cancer: New Dimensions
Douglas Hanahan
Cancer Discovery (2022) Vol. 12, Iss. 1, pp. 31-46
Open Access | Times Cited: 3290
Gut microbiome and health: mechanistic insights
Willem M. de Vos, Herbert Tilg, Matthias Van Hul, et al.
Gut (2022) Vol. 71, Iss. 5, pp. 1020-1032
Open Access | Times Cited: 1424
Targeting the gut and tumor microbiota in cancer
Elizabeth M. Park, Manoj Chelvanambi, Neal Bhutiani, et al.
Nature Medicine (2022) Vol. 28, Iss. 4, pp. 690-703
Closed Access | Times Cited: 321
Gut microbiota in colorectal cancer development and therapy
Chi Chun Wong, Jun Yu
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 7, pp. 429-452
Closed Access | Times Cited: 286
Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies
Yuting Lu, Xiangliang Yuan, Miao Wang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 271
Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications
Lin-Yong Zhao, Jia-Xin Mei, Gang Yu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 158
Inflammation: the incubator of the tumor microenvironment
Dominic Denk, Florian R. Greten
Trends in cancer (2022) Vol. 8, Iss. 11, pp. 901-914
Closed Access | Times Cited: 151
Targeting the gut microbiota for cancer therapy
Miriam R. Fernandes, Poonam Aggarwal, Raquel Costa, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 12, pp. 703-722
Closed Access | Times Cited: 149
Fusobacterium nucleatum-derived succinic acid induces tumor resistance to immunotherapy in colorectal cancer
Shanshan Jiang, Yile Xie, Xiuying Xiao, et al.
Cell Host & Microbe (2023) Vol. 31, Iss. 5, pp. 781-797.e9
Open Access | Times Cited: 139
Targeting PD-L2–RGMb overcomes microbiome-related immunotherapy resistance
Joon Seok Park, Francesca S. Gazzaniga, Meng–Huang Wu, et al.
Nature (2023) Vol. 617, Iss. 7960, pp. 377-385
Open Access | Times Cited: 106
A Review of Gut Microbiota‐Derived Metabolites in Tumor Progression and Cancer Therapy
Qiqing Yang, Bin Wang, Qinghui Zheng, et al.
Advanced Science (2023) Vol. 10, Iss. 15
Open Access | Times Cited: 99
Lactobacillus gallinarum-derived metabolites boost anti-PD1 efficacy in colorectal cancer by inhibiting regulatory T cells through modulating IDO1/Kyn/AHR axis
Winnie Fong, Qing Li, Fenfen Ji, et al.
Gut (2023) Vol. 72, Iss. 12, pp. 2272-2285
Open Access | Times Cited: 91
DietaryLactobacillus-Derived Exopolysaccharide Enhances Immune-Checkpoint Blockade Therapy
Hirotaka Kawanabe-Matsuda, Kazuyoshi Takeda, Marie Nakamura, et al.
Cancer Discovery (2022) Vol. 12, Iss. 5, pp. 1336-1355
Open Access | Times Cited: 88
Immune checkpoint blockade induces gut microbiota translocation that augments extraintestinal antitumor immunity
Yongbin Choi, Jake Lichterman, Laura Coughlin, et al.
Science Immunology (2023) Vol. 8, Iss. 81
Open Access | Times Cited: 67
Intestinal bacteria and colorectal cancer: etiology and treatment
Michael W. Dougherty, Christian Jobin
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 54
Towards modulating the gut microbiota to enhance the efficacy of immune-checkpoint inhibitors
Rebecca Simpson, Erin R. Shanahan, Richard A. Scolyer, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 10, pp. 697-715
Closed Access | Times Cited: 53
Combining gut microbiota modulation and chemotherapy by capecitabine-loaded prebiotic nanoparticle improves colorectal cancer therapy
Tianqun Lang, Runqi Zhu, Xiao Zhu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 50
Role of the microbiota in response to and recovery from cancer therapy
Stephen J. Blake, Yochai Wolf, Ben Boursi, et al.
Nature reviews. Immunology (2023) Vol. 24, Iss. 5, pp. 308-325
Closed Access | Times Cited: 46
Modulating gut microbiome in cancer immunotherapy: Harnessing microbes to enhance treatment efficacy
Xing Kang, Harry Cheuk-Hay Lau, Jun Yu
Cell Reports Medicine (2024) Vol. 5, Iss. 4, pp. 101478-101478
Open Access | Times Cited: 41
Cold and hot tumors: from molecular mechanisms to targeted therapy
Bo Wu, Bo Zhang, Bowen Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 39
Critical role of the gut microbiota in immune responses and cancer immunotherapy
Ze-Hua Li, Weixi Xiong, Liang Zhu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 34
Microbial transmission in the social microbiome and host health and disease
Amar Sarkar, Cameron J.A. McInroy, Siobhán Harty, et al.
Cell (2024) Vol. 187, Iss. 1, pp. 17-43
Open Access | Times Cited: 33
Gut microbiota reshapes cancer immunotherapy efficacy: Mechanisms and therapeutic strategies
Jindong Xie, Manqing Liu, Xinpei Deng, et al.
iMeta (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 31
Fecal microbiota transplantation: no longer cinderella in tumour immunotherapy
Yunwei Yang, Yaping An, Yue Dong, et al.
EBioMedicine (2024) Vol. 100, pp. 104967-104967
Open Access | Times Cited: 19
The gut microbiome and cancer response to immune checkpoint inhibitors
Francesca S. Gazzaniga, Dennis L. Kasper
Journal of Clinical Investigation (2025) Vol. 135, Iss. 3
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top